Meiji Yasuda Asset Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.51M | Buy |
14,001
+3,006
| +27% | +$748K | 0.18% | 156 |
|
|
2025
Q4 | $3.03M | Buy |
10,995
+182
| +2% | +$49.8K | 0.15% | 175 |
|
|
2025
Q3 | $2.84M | Buy |
10,813
+1,250
| +13% | +$304K | 0.14% | 180 |
|
|
2025
Q2 | $2.09M | Sell |
9,563
-685
| -7% | -$146K | 0.1% | 200 |
|
|
2025
Q1 | $2.29M | Sell |
10,248
-737
| -7% | -$203K | 0.09% | 221 |
|
|
2024
Q4 | $3.6M | Buy |
10,985
+7,744
| +239% | +$2.44M | 0.14% | 168 |
|
|
2024
Q3 | $973K | Sell |
3,241
-5,266
| -62% | -$1.61M | 0.04% | 312 |
|
|
2024
Q2 | $2.8M | Buy |
8,507
+278
| +3% | +$98.2K | 0.11% | 184 |
|
|
2024
Q1 | $3.26M | Sell |
8,229
-2,070
| -20% | -$766K | 0.14% | 173 |
|
|
2023
Q4 | $3.63M | Buy |
10,299
+5,135
| +99% | +$1.82M | 0.16% | 166 |
|
|
2023
Q3 | $1.94M | Buy |
5,164
+218
| +4% | +$84.3K | 0.09% | 238 |
|
|
2023
Q2 | $1.89M | Sell |
4,946
-336
| -6% | -$120K | 0.09% | 215 |
|
|
2023
Q1 | $1.83M | Buy |
5,282
+1,417
| +37% | +$414K | 0.09% | 217 |
|
|
2022
Q4 | $910 | Buy |
3,865
+574
| +17% | +$136K | 0.04% | 330 |
|
|
2022
Q3 | $810K | Buy |
3,291
+488
| +17% | +$149K | 0.05% | 332 |
|
|
2022
Q2 | $848K | Buy |
2,803
+145
| +5% | +$47.2K | 0.05% | 355 |
|
|
2022
Q1 | $1.09M | Buy |
2,658
+273
| +11% | +$107K | 0.06% | 311 |
|
|
2021
Q4 | $1.12M | Buy |
2,385
+58
| +2% | +$25K | 0.07% | 254 |
|
|
2021
Q3 | $988K | Buy |
2,327
+182
| +8% | +$76.7K | 0.07% | 257 |
|
|
2021
Q2 | $770K | Buy |
2,145
+1,230
| +134% | +$406K | 0.04% | 304 |
|
|
2021
Q1 | $258K | Buy |
915
+110
| +14% | +$31.5K | 0.02% | 459 |
|
|
2020
Q4 | $228K | Sell |
805
-15
| -2% | -$4.21K | 0.02% | 383 |
|
|
2020
Q3 | $225K | Sell |
820
-140
| -15% | -$37K | 0.02% | 349 |
|
|
2020
Q2 | $218K | Buy |
+960
| New | +$189K | 0.02% | 445 |
|
Other funds holding WST
VCM
VPM
GIM
